Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Multicentric Study for External Validation of a Deep Learning Model for Mammographic Breast Density Categorization

19 de agosto de 2021 actualizado por: Hospital Italiano de Buenos Aires
The correct categorization of breast density is essential to adapt the diagnostic examination to the needs of each patient. Assessment of breast density is performed visually by radiologists. Some authors have detected that this method involves considerable intra and interobserver variability. On the other hand, automated systems for measuring breast density are becoming more and more frequent. Machine learning is a domain of Artificial Intelligence, which comprises the process of developing systems with the ability to learn and make predictions using data. These systems are designed to aid healthcare professional decision making. In the present work, the multicenter study of external validation of a tool based on deep learning for the categorization of mammographic breast density is proposed.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Descripción detallada

The correct categorization of breast density is essential to adapt the diagnostic examination to the needs of each patient. Assessment of breast density is performed visually by radiologists. Some authors have detected that this method involves considerable intra and interobserver variability. On the other hand, automated systems for measuring breast density are becoming more and more frequent. Consequently, in clinical practice, breast density is reported from the assessment carried out by specialists with the support of these systems. But there are few studies about the use, concordance and perception of usefulness of professionals on these tools. A study carried out at the Hospital Italiano de Buenos Aires reported a moderate to almost perfect inter- and intra-observer agreement among radiologists and a moderate concordance between the categorization carried out by experts and that carried out by commercial software of a digital mammography machine. Machine learning is a domain of Artificial Intelligence, which comprises the process of developing systems with the ability to learn and make predictions using data. Once a system designed to aid healthcare professional decision making is developed, it must be validated. In 2019, an internal validation of a tool based on deep learning techniques was carried out for the automatic categorization of mammographic breast density. The tool reached a very good interobserver agreement, kappa = 0.64 (95% CI 0.58-0.69), when compared with the performance of the professionals. It reached a sensitivity of 83.2 (CI: 76.9-88.3) and a specificity of 88.4 (83.9-92.0.) In the present work, the multicenter study of external validation of a tool based on deep learning for the categorization of mammographic breast density is proposed. The evaluation of this tool will be carried out in two external institutions: Hospital Alemán and Fundación Científica del Sur.

Tipo de estudio

De observación

Inscripción (Anticipado)

277

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

The unit of analysis will be the bilateral mammographic images with mediolateral oblique and craniocaudal views. The images selected for this study will be screening mammograms performed at Saint John's Cancer Institute. The institution will select the images according to the inclusion and exclusion criteria. The images will be extracted from the institutional database retrospectively and will be anonymized without any personal data, except for the age of the patient. These images will be stored in DICOM format, in a safe place with restricted access limited only to the investigation team.

Descripción

Inclusion Criteria:

  • Mammograms included in the study should meet the following criteria:

    • Female patients of 40 years of age or more.
    • To have at least one screening mammography exam performed at Saint John's
    • Cancer Institute during the study period. These exams will be included regardless of the brand of the mammography equipment.
    • Mammograms should be performed with digital equipment.

Exclusion Criteria:

  • Mammograms with the following criteria will be excluded from the study:

    • Patients with gigantomastia, defined by the need for more than one image of each mammographic view (mediolateral oblique and craniocaudal) to evaluate the entire breast volume.
    • Patients with breast implants.
    • Patients with a history of breast surgery.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Agreement between the majority report and Artemisia´s categorization of dense breasts/non-dense breasts
Periodo de tiempo: 2 months
The agreement between the CNN and the total of the professionals' categorizations will be calculated with the linear weighted kappa. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images.
2 months
Agreement between the majority report and Artemisia in each one of the four breast density categories
Periodo de tiempo: 2 months
For each one of the professionals involved in the study, the agreement with the CNN will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images.
2 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Agreement between each observer and Artemisia´s categorization of dense breasts/non-dense breasts
Periodo de tiempo: 2 months
To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images.
2 months
Agreement between each observer and Artemisia in each one of the four breast density categories
Periodo de tiempo: 2 months
For each one of the professionals involved in the study, the agreement with the CNN will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images.
2 months
Agreement between each observer and the majority report in the categorization of dense breasts/non-dense breasts
Periodo de tiempo: 2 months
For each one of the professionals involved in the study, the agreement with the majority report will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by the majority report for the same set of images.
2 months
Agreement between each observer and the majority report in each one of the four breast density categories
Periodo de tiempo: 2 months
For each one of the professionals involved in the study, the agreement with the majority report will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by the majority report for the same set of images.
2 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Daniel R Luna, MD, Hospital Italiano de Buenos Aires

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Anticipado)

1 de septiembre de 2021

Finalización primaria (Anticipado)

1 de abril de 2022

Finalización del estudio (Anticipado)

1 de julio de 2022

Fechas de registro del estudio

Enviado por primera vez

19 de agosto de 2021

Primero enviado que cumplió con los criterios de control de calidad

19 de agosto de 2021

Publicado por primera vez (Actual)

25 de agosto de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

25 de agosto de 2021

Última actualización enviada que cumplió con los criterios de control de calidad

19 de agosto de 2021

Última verificación

1 de julio de 2021

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 6077
  • 4927 (PRIISA)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Cáncer de mama

3
Suscribir